Discover
RPID
Rapid Micro Biosystems, Inc.
2.07
1 x 2.07
7 x 2.09
bid
ask
-
0.03
1.43%
12:02 PM
timesize
| Ytd | -28.62% | |
| 1y | -43.75% |
2.03
day range
2.15
1.66
52 week range
4.94
| Open | 2.08 | Prev Close | 2.10 | Low | 2.03 | High | 2.15 | Mkt Cap | 95.18M |
| Vol | 54.49K | Avg Vol | 185.84K | EPS | -1.12 | P/E | -1.87 | Forward P/E | -1.02 |
| Beta | 1.46 | Short Ratio | 0.38 | Inst. Own | 57.65% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-13 | 50-d Avg | 1.95 | 200-d Avg | 3.00 | 1yr Est | 8.00 |
| Income Statement | |||
| Total Revenue | 8.00M | ||
| Revenues (USD) | 8.00M | ||
| Cost of Revenue | 7.63M | ||
| Gross Profit | 371.00K | ||
| Operating Expenses | 14.22M | ||
| Research and Development Expense | 3.36M | ||
| Selling, General and Administrative Expense | 10.86M | ||
| Operating Income | -13.85M | ||
| Interest Expense | 639.00K | ||
| Income Tax Expense | 8.00K | ||
| Net Income | -14.27M | ||
| Net Income Common Stock | -14.27M | ||
| Net Income Common Stock (USD) | -14.27M | ||
| Consolidated Income | -14.27M | ||
| Earnings per Basic Share | -0.31 | ||
| Earnings per Basic Share (USD) | -0.31 | ||
| Earnings per Diluted Share | -0.31 | ||
| Earning Before Interest & Taxes (EBIT) | -13.63M | ||
| Earning Before Interest & Taxes (USD) | -13.63M | ||
| Weighted Average Shares | 45.43M | ||
| Weighted Average Shares Diluted | 45.43M | ||
| Balance Sheet | |||
| Cash and Equivalents | 14.10M | ||
| Cash and Equivalents (USD) | 14.10M | ||
| Investments | 9.13M | ||
| Investments Current | 9.13M | ||
| Trade and Non-Trade Receivables | 6.37M | ||
| Current Assets | 49.23M | ||
| Property, Plant & Equipment Net | 12.61M | ||
| Total Assets | 62.36M | ||
| Debt Current | 1.32M | ||
| Total Debt | 23.71M | ||
| Current Liabilities | 19.12M | ||
| Debt Non-Current | 22.39M | ||
| Total Liabilities | 41.97M | ||
| Accumulated Retained Earnings (Deficit) | -536.67M | ||
| Accumulated Other Comprehensive Income | -1000 | ||
| Shareholders Equity | 20.40M | ||
| Shareholders Equity (USD) | 20.40M | ||
| Assets Non-Current | 13.14M | ||
| Total Debt (USD) | 23.71M | ||
| Deferred Revenue | 6.63M | ||
| Inventory | 17.45M | ||
| Liabilities Non-Current | 22.85M | ||
| Trade and Non-Trade Payables | 4.67M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.01M | ||
| Net Cash Flow from Financing | 247.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.21M | ||
| Capital Expenditure | -394.00K | ||
| Issuance (Purchase) of Equity Shares | 256.00K | ||
| Issuance (Repayment) of Debt Securities | -9.00K | ||
| Net Cash Flow from Investing | 8.60M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 8.99M | ||
| Net Cash Flow from Operations | -15.06M | ||
| Share Based Compensation | 1.22M | ||